The cellular/molecular abnormalities of Alzheimer's disease are also present in older patients with Down's syndrome and in some old nondemented individuals. To evaluate these changes, it is essential to have optimally prepared tissues from clinically well-characterized cases who lack other confounding illnesses. Core C includes a staff of neuropathologists, neuroanatomists, other basic scientists, a clinical coordinator, and technical personnel. The professional staff of Core C arranges autopsies, neuropathological diagnosis, and coordinates the use of tissues for research. These scientists also direct the technical staff and laboratory facilities involved in histology, immunocytochemistry, neurochemistry, receptor autoradiography, and computer-assisted imaging (i.e., for morphometry, autoradiography, in situ hybridization, and Northern and Western blots). The clinical coordinator works with patients, families, and clinicians to facilitate autopsies. The technical staff assists with autopsy procedures and brain dissections, performs histological processing and staining of diagnostic and research material, accessions and stores tissues for distribution to investigators, assists with preparation of tissues or neurochemical and autoradiographic studies, and maintains and operates the image analysis systems. Finally, members of the Core C staff participate in projects of the Consorium to Establish a Registry for Alzheimer's Disease (CERAD) and contribute significantly to the training of physicians and scientists on issues relevant to aging, Alzheimer's disease, and Down's syndrome.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-08
Application #
3809238
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Kaji, Seiji; Maki, Takakuni; Kinoshita, Hisanori et al. (2018) Pathological Endogenous ?-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. Stem Cell Reports 10:356-365
Na, Chan Hyun; Barbhuiya, Mustafa A; Kim, Min-Sik et al. (2018) Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini. Genome Res 28:25-36
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Albert, Marilyn; Zhu, Yuxin; Moghekar, Abhay et al. (2018) Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain :
Oh, Esther S; Blennow, Kaj; Bigelow, George E et al. (2018) Abnormal CSF amyloid-?42 and tau levels in hip fracture patients without dementia. PLoS One 13:e0204695
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Tsapkini, Kyrana; Webster, Kimberly T; Ficek, Bronte N et al. (2018) Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trial. Alzheimers Dement (N Y) 4:461-472
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10

Showing the most recent 10 out of 830 publications